Charles Schwab’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $595K | Buy |
|
|||||
|
2025
Q2 | $281K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $57.6K | Sell |
|
|||||
|
2024
Q1 | $299K | Buy |
|
|||||
|
2023
Q4 | $200K | Sell |
|
|||||
|
2023
Q3 | $972K | Buy |
|
|||||
|
2023
Q2 | $927K | Sell |
|
|||||
|
2023
Q1 | $1.65M | Sell |
|
|||||
|
2022
Q4 | $3.62M | Buy |
|
|||||
|
2022
Q3 | $3.05M | Buy |
|
|||||
|
2022
Q2 | $2.77M | Sell |
|
|||||
|
2022
Q1 | $3.78M | Sell |
|
|||||
|
2021
Q4 | $4.54M | Buy |
|
|||||
|
2021
Q3 | $5.63M | Buy |
|
|||||
|
2021
Q2 | $5.08M | Buy |
|
|||||
|
2021
Q1 | $7.47M | Buy |
|
|||||
|
2020
Q4 | $4.23M | Buy |
|
|||||
|
2020
Q3 | $3.54M | Sell |
|
|||||
|
2020
Q2 | $4.78M | Buy |
|
|||||
|
2020
Q1 | $3.49M | Buy |
|
|||||
|
2019
Q4 | $4.1M | Buy |
|
|||||
|
2019
Q3 | $4.54M | Buy |
|
|||||
|
2019
Q2 | $4.21M | Buy |
|
|||||
|
2019
Q1 | $3.73M | Buy |
|
|||||
|
2018
Q4 | $2.39M | Buy |
|
|||||
|
2018
Q3 | $4.35M | Buy |
|
|||||
|
2018
Q2 | $1.14M | Buy |
|
|||||
|
2018
Q1 | $673K | Hold |
|
|||||
|
2017
Q4 | $666K | Buy |
|
|||||
|
2017
Q3 | $536K | Hold |
|
|||||
|
2017
Q2 | $603K | Sell |
|
|||||
|
2017
Q1 | $729K | Buy |
|
|||||
|
2016
Q4 | $257K | Hold |
|
|||||
|
2016
Q3 | $231K | Hold |
|
|||||
|
2016
Q2 | $133K | Hold |
|
|||||
|
2016
Q1 | $172K | Hold |
|
|||||
|
2015
Q4 | $466K | Hold |
|
|||||
|
2015
Q3 | $395K | Buy |
|
|||||
|
2015
Q2 | $240K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $215K | Buy |
|